Management of infected transvenous permanent pacemakers.
D002512:Cephalothin / Q000627:therapeutic use; D048909:Diabetes Complications; D004567:Electrodes, Implanted; D006801:Humans; D009675:Novobiocin / Q000627:therapeutic use; D010068:Oxacillin / Q000627:therapeutic use; D010138:Pacemaker, Artificial / Q000009:adverse effects* / Q000379:methods; D010406:Penicillins / Q000627:therapeutic use; D012092:Replantation; D018805:Sepsis / Q000628:therapy; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000628:therapy; D013307:Streptomycin / Q000627:therapeutic use; D013530:Surgical Wound Infection / Q000150:complications / Q000628:therapy*; D014693:Ventricular Fibrillation / Q000209:etiology
D010406:Penicillins; D009675:Novobiocin; D002512:Cephalothin; D010068:Oxacillin; D013307:Streptomycin